Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan

Abstract Background Heterocyclic aromatic amines (HAAs) may confer prostate cancer risk; however, the evidence is inconclusive and the activity of HAA-metabolizing enzymes is modulated by gene variants. The purpose of our study was to determine whether there was evidence of an association between HA...

Full description

Bibliographic Details
Main Authors: Masahide Koda, Motoki Iwasaki, Yuko Yamano, Xi Lu, Takahiko Katoh
Format: Article
Language:English
Published: Komiyama Printing Co. Ltd 2017-10-01
Series:Environmental Health and Preventive Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12199-017-0681-0